Volume 30, Number 7—July 2024
CME ACTIVITY - Perspective
Infectious Diseases and Clinical Xenotransplantation
Figure

Figure. Advances in genetic engineering have led to the breeding of pigs with advantages in infection, immunology, coagulation, size, and inflammation. Breeding of source animals in biosecure facilities enables screening for potential pathogens. B4GalNT2, glycosyltransferase; CD46, human membrane cofactor protein; CD47, block SIRPα tyrosine phosphorylation; CD55, human decay-accelerating factor; CMAH, cytidine monophosphate-N-acetylneuraminic acid hydroxylase; EPCR, endothelial cell protein C receptor; GGAT1, α-1,3-glycosyltransferase; HO1, heme oxygenase-1; HA20, human A20; PERV, porcine endogenous retrovirus; THBD, human thrombomodulin gene.
Page created: June 03, 2024
Page updated: June 20, 2024
Page reviewed: June 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.